Pulmonary Fibrosis in COVID-19 Recovered Patients: Problem and Potential Management
- PMID: 33707912
 - PMCID: PMC7922461
 - DOI: 10.5005/jp-journals-10071-23733
 
Pulmonary Fibrosis in COVID-19 Recovered Patients: Problem and Potential Management
Abstract
How to cite this article: B, Khanna P, Sarkar S. Pulmonary Fibrosis in COVID-19 Recovered Patients: Problem and Potential Management. Indian J Crit Care Med 2021;25(2):242-244.
Keywords: COVID-19; Coronavirus disease; Pulmonary fibrosis; SARS-CoV-2; Severe acute respiratory syndrome coronavirus 2.
Copyright © 2021; Jaypee Brothers Medical Publishers (P) Ltd.
Conflict of interest statement
Source of support: Nil Conflict of interest: None
References
- 
    
- Thille AW, Esteban A, Fernández-Segoviano P, Rodriguez JM, Aramburu JA, Vargas-Errázuriz P, et al. Chronology of histological lesions in acute respiratory distress syndrome with diff use alveolar damage: a prospective cohort study of clinical autopsies. Lancet Respir Med. 2013;1(5):395–401. doi: 10.1016/S2213-2600(13)70053-5. DOI: - DOI - PubMed
 
 
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous